Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies

NCT02333188 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT02333188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02333188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Genotype-Guided Dosing Study of FOLFIRABRAX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2014
Completion date
December 31, 2017
Enrollment
50 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of unknown primary, adult cholangiocarcinoma, gallbladder carcinoma, gastric adenocarcinoma, malignant gastrointestinal neoplasm, metastatic pancreatic adenocarcinoma, pancreatic adenocarcinoma, stage iii ampulla of vater cancer, stage iii pancreatic cancer, stage iiia gallbladder cancer, stage iiia gastric cancer, stage iiib gallbladder cancer, stage iiib gastric cancer, stage iv ampulla of vater cancer, stage iv gallbladder cancer, stage iv gastric cancer, stage iv pancreatic cancer